Please login to the form below

Not currently logged in

Indegene acquires DT Associates

Provides end-to-end enterprise solution for customer excellence – from consulting to operations

Indegene, a leading next-generation solutions organisation for the life sciences industry globally, has entered into an agreement to acquire a majority stake in London-based DT Associates, a consulting company exclusively focused on helping pharmaceutical companies achieve excellence in Customer Experience (CX) and Digital Operations (DX). DT Associates will operate as a separate entity in Indegene Private Ltd, as DT Consulting, effective immediately.

“Right now we see ife sciences organisations struggle to overhaul their commercial model to close down on shifting customer needs, as well as thrive on business technology changes and operational and capital efficiencies. We believe that the modern commercial organisation is more customer-centric than it was and will deliver enhanced sales with higher profitability by using enterprise-wide capabilities that allow for customer engagement with intelligence, scale, speed and context.

"While we successfully offer extensive capabilities already in customer experience and hybrid selling enablement, marketing technology, data and analytics, and medical expertise, with the addition of DT we can truly help our clients end-to-end – from objectively measuring the current maturity of digital and customer excellence, to designing commercial models that suit them best, to further supporting clients with change management throughout their transformation journeys,” said Manish Gupta, Co-Founder and CEO, Indegene.

“We thank DT’s leadership for supporting this acquisition and look forward to building an even stronger enterprise solution for Customer Excellence”, added Dr Rajesh Nair, Co-Founder & President, Indegene.

Tim van Tongeren, Managing Partner and Co-Founder of DT, said: “It didn’t take long to realize Indegene and DT have a common vision for the future in life sciences. When differentiated customer experiences become the core business driver, you as a consulting and operations partner will be required to define, plan, implement and optimise this for clients. I believe we are uniquely positioned to do so end-to-end with our clients.”

Dennis van Rooij, Managing Partner and Co-Founder of DT, added: “The prospect of helping our clients beyond DX/CX measurement, benchmarking and transformation management consulting, with deep expertise and capabilities in establishing consolidated centres of excellence for digital content, channel operations, performance measurement and customer innovation, is very exciting.”

Since being founded in 2014, DT Associates has successfully helped large pharmaceuticals around the world identify, plan for and capture the commercial opportunity behind their DX/CX transformation, and has developed proprietary solutions for the objective measurement of Customer Experience (CX) and Digital Maturity (DX). Next to its diverse services portfolio, DT Consulting is an industry-leading source ofDX/CX transformation insights, best practices and peer-to-peer networking for DX/CX senior leaders. Its client roster includes companies such as Pfizer, Sanofi, AstraZeneca, Takeda, Novo Nordisk and more.

4th September 2019

From: Marketing


Featured jobs

Subscribe to our email news alerts


Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...